BRPI0413190A - múltiplas caracterìsticas proteÈmicas séricas de alta resolução para detecção de cáncer de ovário - Google Patents

múltiplas caracterìsticas proteÈmicas séricas de alta resolução para detecção de cáncer de ovário

Info

Publication number
BRPI0413190A
BRPI0413190A BRPI0413190-8A BRPI0413190A BRPI0413190A BR PI0413190 A BRPI0413190 A BR PI0413190A BR PI0413190 A BRPI0413190 A BR PI0413190A BR PI0413190 A BRPI0413190 A BR PI0413190A
Authority
BR
Brazil
Prior art keywords
high resolution
ovarian cancer
sensitivity
resolution mass
spectral data
Prior art date
Application number
BRPI0413190-8A
Other languages
English (en)
Inventor
Peter A Levine
Ben A Hitt
Lance A Liotta
Emanuel F Petricoin
Original Assignee
Correlogic Systems Inc
Government Of The Unidet State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Correlogic Systems Inc, Government Of The Unidet State filed Critical Correlogic Systems Inc
Publication of BRPI0413190A publication Critical patent/BRPI0413190A/pt

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/10—Signal processing, e.g. from mass spectrometry [MS] or from PCR
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding

Landscapes

  • Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Medical Informatics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Theoretical Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Evolutionary Biology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Artificial Intelligence (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Public Health (AREA)
  • Software Systems (AREA)
  • Epidemiology (AREA)
  • Databases & Information Systems (AREA)
  • Data Mining & Analysis (AREA)
  • Evolutionary Computation (AREA)
  • Bioethics (AREA)
  • Signal Processing (AREA)
  • Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

"MULTIPLAS CARACTERìSTICAS PROTEÈMICAS SéRICAS DE ALTA RESOLUçãO PARA DETECçãO DE CáNCER DE OVáRIO". A presente invenção refere-se a um conjunto de estudo de soro bem controlado (n = 248) de mulheres, acompanhadas e avaliadas quanto à presença de câncer de ovário foi utilizado para estender a análise do padrão proteómico de soropara uma plataforma de instrumento espectrómetro de massa de alta resolução, para explorar a existência de conjuntos de características diagnósticas altamente precisas distintas múltiplas presentes no mesmo espectro de massa. Conjuntos de características proteómicas diagnósticas altamente precisas existem dentro de espectro de massa de soros humanos. Utilizando dados espectrais de massa de alta resolução, pelo menos 56 diferentes padrões foram descobertos, que alcançam mais de 85% de sensibilidade e especificamente na testagem e avaliação. Quatro dos conjuntos de características apresentaram 100% de sensibilidade e especificidade em validação vendada. A sensibilidade e a especificidade de modelos diagnósticos gerados a partir de dados espectrais de massa de alta resolução foram superiores a (p< 0,00001) àquelas de dados espectrais de massa de baixa resolução utilizando a mesma amostra de entrada.
BRPI0413190-8A 2003-08-01 2004-07-30 múltiplas caracterìsticas proteÈmicas séricas de alta resolução para detecção de cáncer de ovário BRPI0413190A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US49152403P 2003-08-01 2003-08-01
US90242704A 2004-07-30 2004-07-30
PCT/US2004/024413 WO2005011474A2 (en) 2003-08-01 2004-07-30 Multiple high-resolution serum proteomic features for ovarian cancer detection

Publications (1)

Publication Number Publication Date
BRPI0413190A true BRPI0413190A (pt) 2006-10-03

Family

ID=34118868

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0413190-8A BRPI0413190A (pt) 2003-08-01 2004-07-30 múltiplas caracterìsticas proteÈmicas séricas de alta resolução para detecção de cáncer de ovário

Country Status (11)

Country Link
US (1) US20060064253A1 (pt)
EP (1) EP1649281A4 (pt)
JP (1) JP2007501380A (pt)
AU (1) AU2004261222A1 (pt)
BR (1) BRPI0413190A (pt)
CA (1) CA2534336A1 (pt)
EA (1) EA200600346A1 (pt)
IL (1) IL173471A0 (pt)
MX (1) MXPA06001170A (pt)
SG (1) SG145705A1 (pt)
WO (1) WO2005011474A2 (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60135549D1 (de) 2000-06-19 2008-10-09 Correlogic Systems Inc Heuristisches klassifikationsverfahren
AR040711A1 (es) * 2002-07-29 2005-04-13 Us Agriculture Un metodo para verificacion de calidad/control de calidad para proceso de bioensayo de alto rendimiento
US7425700B2 (en) 2003-05-22 2008-09-16 Stults John T Systems and methods for discovery and analysis of markers
WO2007053170A2 (en) * 2005-02-09 2007-05-10 Correlogic Systems, Inc. Identification of bacteria and spores
US20080312514A1 (en) * 2005-05-12 2008-12-18 Mansfield Brian C Serum Patterns Predictive of Breast Cancer
US7972802B2 (en) 2005-10-31 2011-07-05 University Of Washington Lipoprotein-associated markers for cardiovascular disease
US7736905B2 (en) * 2006-03-31 2010-06-15 Biodesix, Inc. Method and system for determining whether a drug will be effective on a patient with a disease
EP2076860B1 (en) * 2006-09-28 2016-11-16 Private Universität für Gesundheitswissenschaften Medizinische Informatik und Technik - UMIT Feature selection on proteomic data for identifying biomarker candidates
EP2682746B1 (en) * 2007-02-01 2017-05-24 Phenomenome Discoveries Inc. Methods for the diagnosis of ovarian cancer health states and risk of ovarian cancer health states
US20080201095A1 (en) * 2007-02-12 2008-08-21 Yip Ping F Method for Calibrating an Analytical Instrument
KR20120087885A (ko) 2007-06-29 2012-08-07 안국약품 주식회사 난소암의 예측 마커
US8241861B1 (en) 2008-07-08 2012-08-14 Insilicos, Llc Methods and compositions for diagnosis or prognosis of cardiovascular disease
US20110208433A1 (en) * 2010-02-24 2011-08-25 Biodesix, Inc. Cancer patient selection for administration of therapeutic agents using mass spectral analysis of blood-based samples
DE112012000990B4 (de) 2011-02-24 2024-06-27 Aspira Women's Health Inc. (n.d.Ges.d.Staates Delaware) Biomarker-Panels, Diagnostische Verfahren und Testkits für Eierstockkrebs
WO2013103197A1 (ko) * 2012-01-03 2013-07-11 국립암센터 암 진단 장치
KR101439975B1 (ko) 2012-01-03 2014-11-21 국립암센터 대장암 진단 장치
KR101439977B1 (ko) 2012-01-03 2014-09-12 국립암센터 위암 진단 장치
KR101439981B1 (ko) 2012-01-03 2014-09-12 국립암센터 유방암 진단 장치
EP2741224A1 (en) * 2012-11-20 2014-06-11 Thermo Finnigan LLC Methods for generating local mass spectral libraries for interpreting multiplexed mass spectra
CN117169534A (zh) 2019-08-05 2023-12-05 禧尔公司 用于样品制备、数据生成和蛋白质冠分析的系统和方法

Family Cites Families (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3935562A (en) * 1974-02-22 1976-01-27 Stephens Richard G Pattern recognition method and apparatus
US4075475A (en) * 1976-05-03 1978-02-21 Chemetron Corporation Programmed thermal degradation-mass spectrometry analysis method facilitating identification of a biological specimen
US4122518A (en) * 1976-05-17 1978-10-24 The United States Of America As Represented By The Administrator Of The National Aeronautics & Space Administration Automated clinical system for chromosome analysis
US4697242A (en) * 1984-06-11 1987-09-29 Holland John H Adaptive computing system capable of learning and discovery
US4881178A (en) * 1987-05-07 1989-11-14 The Regents Of The University Of Michigan Method of controlling a classifier system
US5697369A (en) * 1988-12-22 1997-12-16 Biofield Corp. Method and apparatus for disease, injury and bodily condition screening or sensing
WO1991014990A1 (en) * 1990-03-28 1991-10-03 Koza John R Non-linear genetic algorithms for solving problems by finding a fit composition of functions
US5210412A (en) * 1991-01-31 1993-05-11 Wayne State University Method for analyzing an organic sample
US5784162A (en) * 1993-08-18 1998-07-21 Applied Spectral Imaging Ltd. Spectral bio-imaging methods for biological research, medical diagnostics and therapy
US5632957A (en) * 1993-11-01 1997-05-27 Nanogen Molecular biological diagnostic systems including electrodes
US6114114A (en) * 1992-07-17 2000-09-05 Incyte Pharmaceuticals, Inc. Comparative gene transcript analysis
WO1994006099A1 (en) * 1992-09-01 1994-03-17 Apple Computer, Inc. Improved vector quantization
CA2512290C (en) * 1993-05-28 2010-02-02 Baylor College Of Medicine Method and apparatus for desorption and ionization of analytes
US5995645A (en) * 1993-08-18 1999-11-30 Applied Spectral Imaging Ltd. Method of cancer cell detection
US5352613A (en) * 1993-10-07 1994-10-04 Tafas Triantafillos P Cytological screening method
US5553616A (en) * 1993-11-30 1996-09-10 Florida Institute Of Technology Determination of concentrations of biological substances using raman spectroscopy and artificial neural network discriminator
US6025128A (en) * 1994-09-29 2000-02-15 The University Of Tulsa Prediction of prostate cancer progression by analysis of selected predictive parameters
WO1996012187A1 (en) * 1994-10-13 1996-04-25 Horus Therapeutics, Inc. Computer assisted methods for diagnosing diseases
US5848177A (en) * 1994-12-29 1998-12-08 Board Of Trustees Operating Michigan State University Method and system for detection of biological materials using fractal dimensions
GB2301897B (en) * 1995-06-08 1999-05-26 Univ Wales Aberystwyth The Composition analysis
KR100197580B1 (ko) * 1995-09-13 1999-06-15 이민화 무선 통신망을 이용한 실시간 생체신호모니터링시스템
US5716825A (en) * 1995-11-01 1998-02-10 Hewlett Packard Company Integrated nucleic acid analysis system for MALDI-TOF MS
US5687716A (en) * 1995-11-15 1997-11-18 Kaufmann; Peter Selective differentiating diagnostic process based on broad data bases
DE19543020A1 (de) * 1995-11-18 1997-05-22 Boehringer Mannheim Gmbh Verfahren und Vorrichtung zur Bestimmung von analytischen Daten über das Innere einer streuenden Matrix
US5760761A (en) * 1995-12-15 1998-06-02 Xerox Corporation Highlight color twisting ball display
US5839438A (en) * 1996-09-10 1998-11-24 Neuralmed, Inc. Computer-based neural network system and method for medical diagnosis and interpretation
EP0935789A1 (en) * 1996-11-04 1999-08-18 3-Dimensional Pharmaceuticals, Inc. System, method, and computer program product for the visualization and interactive processing and analysis of chemical data
US6571227B1 (en) * 1996-11-04 2003-05-27 3-Dimensional Pharmaceuticals, Inc. Method, system and computer program product for non-linear mapping of multi-dimensional data
US20030129589A1 (en) * 1996-11-06 2003-07-10 Hubert Koster Dna diagnostics based on mass spectrometry
AU6816998A (en) * 1997-03-24 1998-10-20 Queen's University At Kingston Coincidence detection method, products and apparatus
US5905258A (en) * 1997-06-02 1999-05-18 Advanced Research & Techology Institute Hybrid ion mobility and mass spectrometer
NZ516848A (en) * 1997-06-20 2004-03-26 Ciphergen Biosystems Inc Retentate chromatography apparatus with applications in biology and medicine
US6081797A (en) * 1997-07-09 2000-06-27 American Heuristics Corporation Adaptive temporal correlation network
US5974412A (en) * 1997-09-24 1999-10-26 Sapient Health Network Intelligent query system for automatically indexing information in a database and automatically categorizing users
US6085576A (en) * 1998-03-20 2000-07-11 Cyrano Sciences, Inc. Handheld sensing apparatus
US6128608A (en) * 1998-05-01 2000-10-03 Barnhill Technologies, Llc Enhancing knowledge discovery using multiple support vector machines
US6723564B2 (en) * 1998-05-07 2004-04-20 Sequenom, Inc. IR MALDI mass spectrometry of nucleic acids using liquid matrices
US6311163B1 (en) * 1998-10-26 2001-10-30 David M. Sheehan Prescription-controlled data collection system and method
US5989824A (en) * 1998-11-04 1999-11-23 Mesosystems Technology, Inc. Apparatus and method for lysing bacterial spores to facilitate their identification
US6631333B1 (en) * 1999-05-10 2003-10-07 California Institute Of Technology Methods for remote characterization of an odor
US7057168B2 (en) * 1999-07-21 2006-06-06 Sionex Corporation Systems for differential ion mobility analysis
US6329652B1 (en) * 1999-07-28 2001-12-11 Eastman Kodak Company Method for comparison of similar samples in liquid chromatography/mass spectrometry
US6615199B1 (en) * 1999-08-31 2003-09-02 Accenture, Llp Abstraction factory in a base services pattern environment
DE60135549D1 (de) * 2000-06-19 2008-10-09 Correlogic Systems Inc Heuristisches klassifikationsverfahren
US6680203B2 (en) * 2000-07-10 2004-01-20 Esperion Therapeutics, Inc. Fourier transform mass spectrometry of complex biological samples
US20020059030A1 (en) * 2000-07-17 2002-05-16 Otworth Michael J. Method and apparatus for the processing of remotely collected electronic information characterizing properties of biological entities
AU2001280581A1 (en) * 2000-07-18 2002-01-30 Correlogic Systems, Inc. A process for discriminating between biological states based on hidden patterns from biological data
JP2004536276A (ja) * 2000-11-16 2004-12-02 シファーゲン バイオシステムズ， インコーポレイテッド 質量スペクトルを分析する方法
EP1356121A2 (en) * 2001-02-01 2003-10-29 Ciphergen Biosystems, Inc. Improved methods for protein identification, characterization and sequencing by tandem mass spectrometry
US7299134B2 (en) * 2001-02-16 2007-11-20 Bio-Rad Laboratories, Inc. Method for correlating gene expression profiles with protein expression profiles
WO2002086168A1 (en) * 2001-04-19 2002-10-31 Ciphergen Biosystems, Inc. Biomolecule characterization using mass spectrometry and affinity tags
WO2003014735A1 (en) * 2001-08-03 2003-02-20 General Hospital Corporation System, process and diagnostic arrangement establishing and monitoring medication doses for patients
JP2005500543A (ja) * 2001-08-13 2005-01-06 ビヨンド ジェノミクス， インコーポレイテッド 生物学的系をプロファイリングするための方法およびシステム
AU2003235749A1 (en) * 2002-01-07 2003-07-24 John Hopkins University Biomarkers for detecting ovarian cancer
US20020193950A1 (en) * 2002-02-25 2002-12-19 Gavin Edward J. Method for analyzing mass spectra
AR040711A1 (es) * 2002-07-29 2005-04-13 Us Agriculture Un metodo para verificacion de calidad/control de calidad para proceso de bioensayo de alto rendimiento
JP4585167B2 (ja) * 2002-11-29 2010-11-24 東芝医用システムエンジニアリング株式会社 Ｘ線コンピュータ断層撮影システム
CA2548842A1 (en) * 2003-12-11 2005-07-07 Correlogic Systems, Inc. Method of diagnosing biological states through the use of a centralized, adaptive model, and remote sample processing
WO2007053170A2 (en) * 2005-02-09 2007-05-10 Correlogic Systems, Inc. Identification of bacteria and spores

Also Published As

Publication number Publication date
JP2007501380A (ja) 2007-01-25
MXPA06001170A (es) 2006-05-15
EP1649281A4 (en) 2007-11-07
CA2534336A1 (en) 2005-02-10
AU2004261222A2 (en) 2005-02-10
WO2005011474A2 (en) 2005-02-10
WO2005011474A3 (en) 2005-06-09
EP1649281A2 (en) 2006-04-26
AU2004261222A1 (en) 2005-02-10
US20060064253A1 (en) 2006-03-23
SG145705A1 (en) 2008-09-29
EA200600346A1 (ru) 2006-08-25
IL173471A0 (en) 2006-06-11

Similar Documents

Publication Publication Date Title
BRPI0413190A (pt) múltiplas caracterìsticas proteÈmicas séricas de alta resolução para detecção de cáncer de ovário
Prentice et al. A physically motivated classification of stripped-envelope supernovae
Fang et al. A streamlined pipeline for multiplexed quantitative site-specific N-glycoproteomics
Witjes et al. Recently introduced biomarkers for screening of hepatocellular carcinoma: a systematic review and meta-analysis
Monneret et al. How clinical flow cytometry rebooted sepsis immunology
Sallam Proteomics in cancer biomarkers discovery: challenges and applications
Marshall et al. Proteomic mapping of proteins released during necrosis and apoptosis from cultured neonatal cardiac myocytes
Beckwith-Hall et al. NMR-based metabonomic studies on the biochemical effects of commonly used drug carrier vehicles in the rat
Wang et al. Development and validation of a highly sensitive urine-based test to identify patients with colonic adenomatous polyps
US20220108777A1 (en) Biomarkers for detecting colorectal cancer or adenoma and methods thereof
Adachi et al. Association between plasma α‐aminobutyric acid and depressive symptoms in older community‐dwelling adults in Japan
Spencer et al. Matrix-assisted laser desorption/ionization–time of flight-mass spectrometry profiling of trace constituents of condom lubricants in the presence of biological fluids
CA2619732A1 (en) Methods for the diagnosis of colorectal cancer and ovarian cancer health states
Amali et al. Detection of drug‐responsive B lymphocytes and antidrug IgG in patients with β‐lactam hypersensitivity
Wang et al. Identifying biomarkers of endometriosis using serum protein fingerprinting and artificial neural networks
Capuano et al. Simultaneous Proton Transfer Reaction-Mass Spectrometry and electronic nose study of the volatile compounds released by Plasmodium falciparum infected red blood cells in vitro
Hirdman et al. Proteomic characteristics and diagnostic potential of exhaled breath particles in patients with COVID-19
Cao et al. Database-assisted global metabolomics profiling of pleural effusion induced by tuberculosis and malignancy
Amiri-Dashatan et al. Mass spectrometry-based proteomics research to fight COVID-19: An expert review on hopes and challenges
Randolph et al. Quantifying peptide signal in MALDI-TOF mass spectrometry data
Perzanowska et al. An MRM‐Based Cytokeratin Marker Assay as a Tool for Cancer Studies: Application to Lung Cancer Pleural Effusions
Kirkegård et al. Impact on Survival of Early Versus Late Initiation of Adjuvant Chemotherapy After Pancreatic Adenocarcinoma Surgery: A Target Trial Emulation: J. Kirkegård et al.
Ayati et al. A systematic review and network meta-analysis of the association between periodontitis and inflammatory bowel diseases
El Jamal et al. MEF2B is a member of the BCL6 gene transcriptional complex and induces its expression in diffuse large B-cell lymphoma of the germinal center B-cell-like type
Zaimenko et al. Non‐invasive metastasis prognosis from plasma metabolites in stage II colorectal cancer patients: The DACHS study

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]